PARIS — New findings from the controversial ORBITA trial provide a lift for percutaneous coronary intervention (PCI) in stable angina but also mixed results for the predictive power of fractional flow ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

I n the month since its presentation at the American Heart Association 2019 Scientific Sessions, the ISCHEMIA trial has continued to generate discussion and debate. The trial was presented to a packed ...

Among patients with diabetes and without known coronary artery disease and referred for myocardial perfusion imaging, 12.7% had significant ischemia, and 60% had reduced myocardial blood flow reserve ...

Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher ...

PAD typically onsets with no noticeable symptoms. Over time, it can progress and begin causing limb pain and cramping, even when at rest. Early treatment can help to slow the progression and reduce ...

Peripheral vascular disease is a lack of blood flow through the arteries, typically affecting the legs and feet. The main symptoms include pain, numbness, weakness in the legs and feet, skin ...